Vice President, Drug Discovery
Joseph M. Colacino, Ph.D. joined PTC in March 2003, as Vice President of Drug Discovery. Dr. Colacino oversees drug discovery activities across therapeutic areas and brings over 14 years of drug discovery experience from Eli Lilly and Company. At Eli Lilly, he held positions as Research Acquisition Advisor, Director of Virology, and Head of Biology for Infectious Diseases Research. In that capacity, Dr. Colacino initiated and directed research programs in Infectious Diseases and managed a number of internal committees involved in the evaluation of screening methodologies and scientific approaches. Dr. Colacino is widely published and serves on the editorial boards of Antimicrobial Agents and Chemotherapy, Antiviral Chemistry and Chemotherapy, and Progress in Drug Research and has been an expert reviewer for Journal of Virology, Virology and Proceedings of the National Academy of Science. Dr. Colacino received his Ph.D. in Virology from the Cornell Graduate School of Medical Sciences, New York.